CBmed research areas:
Medical, Scientific and Technological Expertise

The three research areas of CBmed are equal partners within the organization that interact closely with each other along Total Quality Management (TQM) assured processes.

Research area “Precision Medicine Technologies” provides and develops multidisciplinary coretechnologies, including flow cytometry, multiplex immunohistochemistry, metabolomics and data science. Within research area “Cancer Research for Precision Medicine” we focus on liquid biopsy in cancer, translational molecular imaging and the establishment of a novel drug screening platform to enable personalised treatment for each individual patient. The research area “Microbiome Research for Precision Medicine” applies beyond state-of-the-art techniques to understand host-drug-microbiome interactions.

Within all research areas CBmed develops their research projects in cooperation with industry and scientific partners.

Research projects

CBmed Projects aim to develop easily applicable, targeted, minimally invasive biomarkers for better diagnosis, better therapy monitoring and a more personalized treatment of patients.

Identifying new biomarkers

Validating potential biomarkers

Conducting translational biomarker research

The COMET Center CBmed is funded within COMET – Competence Centers for Excellent Technologies by the Federal Ministry of Climate Action, Environment, Energy, Mobility, Innovation and Technology (BMK), the Federal Ministry for Digital and Economic Affairs (BMDW), Land Steiermark (Styrian Business Promotion Agency – SFG) and Land Wien (Vienna Business Agency – WAW). The COMET program is executed by the Austrian Research Promotion Agency (FFG).

CBmed GmbH Center for Biomarker Research in Medicine
Stiftingtalstrasse 5   8010 Graz   Austria   office@cbmed.at   +43 316 385 28801